商品名称
适用类别
通用名称
活性成分
产品号
上市许可持有人/公司名称
上市批准日期
授权状态
Ebglyss
Human
Lebrikizumab
Lebrikizumab
EMEA/H/C/005894
Almirall, S.A.
2023/11/16
Authorised
Herwenda
Human
trastuzumab
trastuzumab
EMEA/H/C/005769
Sandoz GmbH
2023/11/15
Authorised
Aqumeldi
Human
Enalapril maleate
Enalapril (maleate)
EMEA/H/C/005731
Proveca Pharma Limited
2023/11/15
Authorised
Vanflyta
Human
quizartinib
Quizartinib dihydrochloride
EMEA/H/C/005910
Daiichi Sankyo Europe GmbH
2023/11/06
Authorised
Jaypirca
Human
pirtobrutinib
pirtobrutinib
EMEA/H/C/005863
Eli Lilly Nederland B.V.
2023/10/30
Authorised
Degarelix Accord
Human
degarelix
degarelix acetate
EMEA/H/C/006048
Accord Healthcare S.L.U.
2023/09/29
Authorised
Tyruko
Human
natalizumab
natalizumab
EMEA/H/C/005752
Sandoz GmbH
2023/09/22
Authorised
Tepkinly
Human
epcoritamab
epcoritamab
EMEA/H/C/005985
AbbVie Deutschland GmbH & Co. KG
2023/09/22
Authorised
Apretude
Human
cabotegravir
Cabotegravir
EMEA/H/C/005756
ViiV Healthcare B.V.
2023/09/15
Authorised
Litfulo
Human
ritlecitinib
ritlecitinib tosilate
EMEA/H/C/006025
Pfizer Europe MA EEIG
2023/09/15
Authorised
Yesafili
Human
aflibercept
aflibercept
EMEA/H/C/006022
Viatris Limited
2023/09/15
Authorised
Lyfnua
Human
gefapixant
Gefapixant
EMEA/H/C/005476
Merck Sharp & Dohme B.V.
2023/09/15
Authorised
Inaqovi
Human
cedazuridine, decitabine
cedazuridine, decitabine
EMEA/H/C/005823
Otsuka Pharmaceutical Netherlands B.V.
2023/09/15
Authorised
Tevimbra
Human
tislelizumab
Tislelizumab
EMEA/H/C/005919
Novartis Europharm Limited
2023/09/15
Authorised
Enrylaze
Human
crisantaspase
crisantaspase
EMEA/H/C/005917
Jazz Pharmaceuticals Ireland Limited
2023/09/15
Authorised
Orserdu
Human
elacestrant
elacestrant
EMEA/H/C/005898
Stemline Therapeutics B.V.
2023/09/15
Authorised
Tyenne
Human
tocilizumab
tocilizumab
EMEA/H/C/005781
Fresenius Kabi Deutschland GmbH
2023/09/15
Authorised
Abrysvo
Human
Respiratory syncytial virus vaccine (bivalent, recombinant)
Respiratory syncytial virus, subgroup A, stabilized prefusion F protein / Respiratory syncytial virus, subgroup B, stabilized prefusion F protein
EMEA/H/C/006027
Pfizer Europe MA EEIG
2023/08/23
Authorised
Talvey
Human
talquetamab
talquetamab
EMEA/H/C/005864
Janssen-Cilag International N.V.
2023/08/21
Authorised
Aquipta
Human
atogepant
atogepant
EMEA/H/C/005871
AbbVie Deutschland GmbH & Co. KG
2023/08/11
Authorised
